As the year draws to a close, investors are keen to understand the outlook for the A-share market and potential investment opportunities. Here are the latest insights from Great Wall Fund's healthcare investment team.
Tan Xiaobing: A Potential Window for Market Positioning In November, the market was influenced by U.S. liquidity expectations, with dividend and cyclical sectors performing well while growth stocks lagged. Looking ahead to December, we believe short-term risks may persist. However, with the upcoming Central Economic Work Conference and potential Fed rate cuts, the market could enter a strategic window for positioning toward next year's expectations.
Long Yufei: Sustained Confidence in AI Applications We remain bullish on technology-driven sub-sectors within healthcare and consumer industries, particularly AI applications. Both overseas and domestic markets initially had overly high expectations for AI, but after adjustments, sentiment has normalized. Meanwhile, hardware and infrastructure, such as computing power, have reached a certain scale. AI applications in various fields—especially in B2B and vertical scenarios—are gradually materializing. Coupled with currently low market expectations, the AI application sector may see valuation recovery opportunities.
Liang Furui: Focus on Clinical Data Readouts in Innovative Drugs At this stage, two key areas stand out in innovative drugs: the globalization of companies that have already secured business development (BD) deals and the validation of pipeline value and overseas expansion for those yet to secure BD. While negative sentiment around many innovative drug stocks has largely been digested, December lacks major catalysts like significant data releases or BD deals. Thus, attention will shift to the timing of upcoming clinical data readouts for high-potential pipelines.
Disclaimer: The information herein is sourced from channels deemed reliable and analysts' judgments, but no direct or implied guarantees are provided regarding its accuracy or completeness. This communication does not constitute a full representation of related securities or markets. Opinions expressed are subject to change without notice. Recipients should not rely solely on this content for investment decisions. Neither the company nor its affiliates, employees, or agents assume liability for any losses arising from the use of this material. Unauthorized distribution, reproduction, or modification is prohibited. Investors are reminded of market risks and anti-money laundering obligations.
Comments